Chapter 36: Problem 2
The so far only known endogenous NMDA receptor antagonist is: a. glutamate b. glycine c. ketamine d. kynurenic acid e. quinolinic acid
Chapter 36: Problem 2
The so far only known endogenous NMDA receptor antagonist is: a. glutamate b. glycine c. ketamine d. kynurenic acid e. quinolinic acid
All the tools & learning materials you need for study success - in one app.
Get started for freeThe most common psychiatric side effect of IFN- \(\alpha\) administration is: a. paranoid ideation b. optical and-less frequent-acoustic hallucinations c. manic episodes d. depression e. tics
The limiting step in serotonin synthesis is in all probability: a. tryptophan availability b. serotonin availability in a negative feed back c. tryptophan hydroxylase activity d. a and \(\mathrm{c}\) e. \(b\) and \(c\)
Glucocorticoids: a. induce central nervous production of pro-inflammatory mediators b. inhibit central nervous production of pro-inflammatory mediators c. induce glutamate signal at the NMDA receptor d. inhibit glutamate signal at the NMDA receptor e. \(a\) and \(c\) f. b and \(d\) g. \(b\) and \(c\)
Administration of the \(\mathrm{COX}-2\) inhibitor celecoxib was shown to: a. induce exacerbation of psychotic symptoms in schizophrenia b. improve psychotic and especially cognitive in schizophrenia c. be more efficient in chronic schizophrenia than in the early stages d. enhance antidepressant therapy when added to a conventional antidepressant drug e. \(a\) and \(c\) f. b and \(d\)
The proposed neurotransmitter imbalance in major depression is best characterized by: a. increased serotonin, increased glutamate, reduced norepinephrine b. increased serotonin, increased norepinephrine, reduced glutamate c. increased glutamate, decreased serotonin, decreased norepinephrine d. none of the above
What do you think about this solution?
We value your feedback to improve our textbook solutions.